Compounds exhibiting thrombopoietin-like activities
AssigneeChugai Seiyaku Kabushiki Kaisha
InventorsShinya Fujiwara, Tomokazu Ozaki, Toshiro Kozono, Kunihiro Hattori, Toru Esaki
Life of this patent
Estimating the term…
Loading patent…
AssigneeChugai Seiyaku Kabushiki Kaisha
InventorsShinya Fujiwara, Tomokazu Ozaki, Toshiro Kozono, Kunihiro Hattori, Toru Esaki
Estimating the term…
The compounds of the invention are compounds represented by the following general formula (1): wherein E represents one selected from the group consisting of a methylidyne group and a nitrilo group, R1 represents one selected from the group consisting of optionally substituted aryl groups and optionally substituted heteroaryl groups, R2 represents one selected from the group consisting of a hydrogen atom and alkyl groups, W1 represents an amino acid residue, A represents one selected from the group consisting of a carbonyl group and a sulfonyl group, X1 represents one selected from the group consisting of optionally substituted alkylene groups and optionally substituted alkenylene groups, and p represents 0 or 1; and their pharmacologically acceptable salts, which exhibit thrombopoietin-like activity.
A compound represented by the following general formula (1), or a pharmacologically acceptable salt thereof
A compound production process which comprises a first step of reacting a compound represented by the following general formula (2):
A compound production process which comprises a fourth step of reacting a amino acid derivative and a silylating agent;
Dependencies are inferred from the claim text.